Patent Expiry
Patent/Exclusivity Expiry: SUNOSI
- Drug
- SUNOSI
Other upcoming events for AXSM
Phase 3 ReadoutPhase 3 Topline: A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy and Safety of
Phase 3 ReadoutPhase 3 Topline: An Open-Label Study to Assess the Long-Term Safety and Efficacy of AXS-14 in the Management of Fibro
Phase 3 ReadoutPhase 3 Topline: A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal Study of Solriamfetol in Subj
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.